Bumper Offer - Urjas oil Just @ Rs. 1 X
Revas 25 Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of High BP. The alternative uses of Revas 25 Tablet have also been explained below.
The optimal dosage of Revas 25 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
While these are the most often observed Revas 25 Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Revas 25 Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Revas 25 Tablet's effect during pregnancy is Severe and Mild while nursing. It is important to know if Revas 25 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Revas 25 Tablet related warnings section.
Other contraindications of Revas 25 Tablet have been discussed in the sections ahead.
Besides this, Revas 25 Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Revas 25 Tablet is not safe while driving, and is is not addictive in nature.
Revas 25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Revas 25 Tablet is used -
Moderate
Mild
Is the use of Revas 25 Tablet safe for pregnant women?
Revas shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Revas 25 Tablet safe during breastfeeding?
Revas has been seen to have minimal side effects on breastfeeding women.
What is the effect of Revas 25 Tablet on the Kidneys?
Revas does not damage the kidneys.
What is the effect of Revas 25 Tablet on the Liver?
Revas is rarely harmful for the liver.
What is the effect of Revas 25 Tablet on the Heart?
Revas has very mild side effects on the heart.
Revas 25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Revas 25 Tablet unless your doctor advises you to do so -
Is this Revas 25 Tablet habit forming or addictive?
No, you will not get addicted to Revas 25 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Revas 25 Tablet as you may feel sleepy.
Is it safe?
Revas 25 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Revas 25 Tablet for mental disorders.
Interaction between Food and Revas 25 Tablet
Some foods when eaten with Revas 25 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Revas 25 Tablet
Taking Revas 25 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cozaar® (losartan potassium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 506
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cozaar® (losartan potassium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 506
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cozaar® (losartan potassium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 506
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173